These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 3856076)
1. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076 [TBL] [Abstract][Full Text] [Related]
2. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma. Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272 [TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]. Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133 [TBL] [Abstract][Full Text] [Related]
4. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma. Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651 [TBL] [Abstract][Full Text] [Related]
5. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma. Satake K; Kanazawa G; Kho I; Chung YS; Umeyama K J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396 [TBL] [Abstract][Full Text] [Related]
6. [Tumor markers in the upper intestinal tract--stomach and pancreas]. Pointner R; Conrad F; Schwab G Wien Klin Wochenschr; 1989 Jul; 101(14):482-4. PubMed ID: 2773485 [TBL] [Abstract][Full Text] [Related]
7. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919 [TBL] [Abstract][Full Text] [Related]
8. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9]. Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003 [No Abstract] [Full Text] [Related]
9. The value of CA 19-9 in gastric and colorectal carcinoma. Safi F; Bittner R; Roscher R; Kübel R; Beger HG Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768 [TBL] [Abstract][Full Text] [Related]
10. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison. von Kleist S Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9. Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158 [TBL] [Abstract][Full Text] [Related]
12. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. Heptner G; Domschke S; Domschke W Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339 [TBL] [Abstract][Full Text] [Related]
13. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum]. Ial'chenko NA; Lagutin VD; Lavik NN; Musin II Vopr Onkol; 1991; 37(9-10):921-4. PubMed ID: 1726842 [TBL] [Abstract][Full Text] [Related]
14. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors]. Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992 [TBL] [Abstract][Full Text] [Related]
15. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma. Szymendera JJ; Nowacki MP; Kozłowicz-Gudzińska I; Kowalska M Dis Colon Rectum; 1985 Dec; 28(12):895-9. PubMed ID: 3864628 [TBL] [Abstract][Full Text] [Related]
16. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer. Kornek G; Depisch D; Temsch EM; Scheithauer W J Cancer Res Clin Oncol; 1991; 117(5):493-6. PubMed ID: 1890143 [TBL] [Abstract][Full Text] [Related]
18. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896 [TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies. Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis]. Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]